Andy Minn, MD, PhD, will return to Memorial Sloan Kettering Cancer Center (MSK) as the inaugural Chair of MSK’s new Immuno-Oncology Program in August.

10 Must-Read Posts in Immuno-Oncology This Week / Alex Menzies, Alexander Van Akkooi, AndrewFurness, cancer, chemoimmunotherapy, Christian Blank, David

Kim and colleagues provide an overview of the current state of the art of nanomaterials and their application in immuno-oncology, discussing preclinical development and the clinical landscape.

Dr. Jason Luke's Journey in Immuno-Oncology Innovation / anti-CTLA-4, cancer, immunotherapy, ipilimumab, Jason J Luke, Melanoma, OncoDaily, Oncology, Ravi Kara

Top 10 must-read immuno-oncology updates this week—covering key breakthroughs, clinical trials, and expert insights shaping cancer immunotherapy.

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology / Agenus, biotech, botensilimab, cancer, cancer care, Cancer

GI Innovation Dosed First Patient in Phase 1 Trial of "GI-102" Immuno-Oncology Drug / cancer, GI INNOVATION, GI-102, immunotherapy, Kim Seung-tae, OncoDaily,

10 Must-Read Posts in Immuno-Oncology This Week / Alicia Zhou, Asha Pillai, Buisseret Laurence, cancer, ESMO, immuno-oncology, Javier Molina Cerrillo, Jeff

Register for European Society for Medical Oncology's Immuno-Oncology Annual Congress / cancer, cell signalling, Cnacer Treatment, epigenetics, ESMO, ESMO

The SITC Neuro Immuno-Oncology: From Challenges to Opportunities Virtual Summit will highlight the current understanding and recent advances in neuro immuno-oncology (NIO) and provide insight on how i...

The Immuno-oncology assays are specialized laboratory tests designed to assess interactions between immune cells and tumors while evaluating therapies that stimulate the body’s immune system to combat cancer. These assays support researchers in measuring drug efficacy, monitoring immune responses, understanding treatment mechanisms, and advancing the development of innovative cancer therapies. The North America Immuno Oncology Assays Market continues to play a pivotal role in advancing cancer research and immunotherapy development.

This week’s expert highlights in immuno-oncology spotlight trial updates, novel combinations, and leading voices shaping the future of cancer immunotherapy.

A roundup of this week’s top immuno-oncology advances—from lncRNA-driven resistance and microbiome biomarkers to new FDA approvals, real-world EV data, and emerging IO biomarkers.

10 Must-Read Posts in Immuno-Oncology This Week / Alicia Zhou, Asha Pillai, Buisseret Laurence, cancer, ESMO, immuno-oncology, Javier Molina Cerrillo, Jeff

Weekly highlights in cancer immunotherapy and immuno-oncology: cabozantinib + atezolizumab, sarcoma IO, radiotherapy crosstalk, durvalumab in SCLC.